Your browser doesn't support javascript.
loading
EIF4EBP1 is transcriptionally upregulated by MYCN and associates with poor prognosis in neuroblastoma.
Voeltzke, Kai; Scharov, Katerina; Funk, Cornelius Maximilian; Kahler, Alisa; Picard, Daniel; Hauffe, Laura; Orth, Martin F; Remke, Marc; Esposito, Irene; Kirchner, Thomas; Schramm, Alexander; Rotblat, Barak; Grünewald, Thomas G P; Reifenberger, Guido; Leprivier, Gabriel.
Afiliación
  • Voeltzke K; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Scharov K; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Funk CM; Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Kahler A; Faculty of Medicine, Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany.
  • Picard D; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hauffe L; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
  • Orth MF; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Remke M; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Esposito I; Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Kirchner T; German cancer consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
  • Schramm A; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Rotblat B; Faculty of Medicine, Max-Eder Research Group for Pediatric Sarcoma Biology, Institute of Pathology, LMU Munich, Munich, Germany.
  • Grünewald TGP; Institute of Neuropathology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Reifenberger G; Department of Pediatric Oncology, Hematology, and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University, Düsseldorf, Germany.
  • Leprivier G; German cancer consortium (DKTK), partner site Essen/Düsseldorf, Düsseldorf, Germany.
Cell Death Discov ; 8(1): 157, 2022 Apr 04.
Article en En | MEDLINE | ID: mdl-35379801
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Discov Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Discov Año: 2022 Tipo del documento: Article País de afiliación: Alemania